Trademark Search in Canada

KYMERA THERAPEUTICS

View On IC.GC.CA

REGISTERED

on 10 Dec 2024

Last Applicant/ Owned by

Kymera Therapeutics, Inc.

300 Technology Square2nd FloorCambridge, MA 02139

Serial Number

1964338 filed on 22^nd May 2019

Registration Number

TMA1274997 registered on 10^th Dec 2024

Registration expiry Date

10^th Dec 2034

Correspondent Address

CPST INTELLECTUAL PROPERTY INC.

130 Queens Quay EastEast Tower, Suite 809Toronto,

ONTARIO

M5A0P6

KYMERA THERAPEUTICS

Trademark usage description

house mark for pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology, immunology, inflammation, and immun Read More

Classification Information

Class [005]
House mark for pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology, immunology, inflammation, and immune-inflammatory diseases; House mark for pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology, immunology, inflammation, and immune-inflammatory diseases; House mark for diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology, immunology, inflammation, and immune-inflammatory diseases

Classification kind code

Class [042]
Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology, immunology, inflammation, and immune-inflammatory diseases; research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; development of pharmaceutical preparations and medicines; drug development and discovery; medical research for development of therapeutic modalities for treatment of diseases; custom design and development of chemical reagents and biochemical assays; clinical studies, namely, clinical research in the field of oncology, immune oncology, autoimmune, immunology, inflammation, and immune-inflammatory disease; preclinical and clinical development of therapeutic products, namely, development of pharmaceutical preparations and medicines.

Classification kind code

Mark Details

Serial Number

1964338

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 17^th Jul 2024	Advertised
Submitted for opposition 26 on 31^st May 2024	Approved
Submitted for opposition 27 on 31^st May 2024	Approval Notice Sent
Submitted for opposition 22 on 21^st Dec 2023	Search Recorded
Submitted for opposition 20 on 21^st Dec 2023	Examiner's First Report
Submitted for opposition 287 on 31^st May 2022	Pre-Assessment Letter Sent
Submitted for opposition 48 on 30^th Oct 2020	Agent Changed
Submitted for opposition 31 on 28^th May 2019	Formalized
Submitted for opposition 1 on 23^rd May 2019	Created
Submitted for opposition 30 on 22^nd May 2019	Filed